Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease
- 1 July 1992
- journal article
- clinical trial
- Published by Springer Nature in Psychopharmacology
- Vol. 108 (1-2) , 103-109
- https://doi.org/10.1007/bf02245293
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The pattern of cerebral activity underlying verbal fluency shown by split-dose single photon emission tomography (SPET or SPECT) in normal volunteersPsychological Medicine, 1991
- Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary FindingsThe Journal of Clinical Pharmacology, 1990
- Elevated Cerebellar Glucose Metabolism in Microvascular White Matter Disease: Normal Aging and Alzheimer's DiseaseJournal of Cerebral Blood Flow & Metabolism, 1988
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Muscarinic receptor compensation in hippocampus of Alzheimer patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Impaired Recall and the Memory Disturbance in Presenile DementiaBritish Journal of Social and Clinical Psychology, 1975
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960